Torrent Pharmaceuticals ROE 2024

Kaj počne Torrent Pharmaceuticals?

Torrent Pharmaceuticals Ltd is a company from India that was founded in 1959. Initially, it exclusively produced generics, which are imitation drugs of existing medications, but over the years it expanded its portfolio. Today, Torrent Pharmaceuticals Ltd is a significant player in the international pharmaceutical market and offers a variety of products. The business model of Torrent Pharmaceuticals Ltd is based on a smart strategy: the company not only focuses on generics but also develops its own active ingredients and patents. Another strength of Torrent Pharmaceuticals Ltd lies in its marketing. It has a strong network of distribution partners in various countries, allowing it to quickly and efficiently respond to local needs. The company is divided into three areas: generics, branded drugs, and API (Active Pharmaceutical Ingredients). In the generics area, Torrent Pharmaceuticals Ltd offers a wide range of medications, from antibiotics to painkillers. It focuses on both the Indian market and international exports. In the branded drugs area, the company develops its own active ingredients and patents and markets them worldwide. It focuses on innovative preparations, such as medications for cancer or diabetes. A well-known product in this area is the cholesterol-lowering drug Rosuvastatin, marketed under the brand name Rosuvas®. In the API area, Torrent Pharmaceuticals Ltd manufactures active ingredients that serve as raw materials for medications. This includes both generics and branded drugs. With this division, the company covers the entire value chain and thus has a high level of control over the quality of its products. Torrent Pharmaceuticals Ltd operates multiple production facilities in India. Here, the various medications are manufactured and quality tested. The company places great importance on adhering to international standards and therefore has a number of certifications. For example, it is certified according to ISO 9001 and ISO 14001 and has British MHRA approval as well as American FDA approval. In recent years, Torrent Pharmaceuticals Ltd has increasingly focused on the international market. It now exports to over 60 countries, including the USA, Europe, and Australia. The company aims to continuously expand its product range and invests in research and development. The company places special emphasis on the quality of its products. It follows a holistic quality approach that extends from development to production to delivery. The company has its own quality control laboratories and collaborates closely with independent testing institutes. This ensures a high quality of its medications and a high level of safety for its customers. In summary, Torrent Pharmaceuticals Ltd is a significant player in the international pharmaceutical market. With its wide range of generics, branded drugs, and API, it adopts a diversified strategy and is well positioned for the future. The company places great importance on the quality of its products and therefore invests in research and development, as well as adherence to international standards. With its focus on international exports and innovative preparations, it is an attractive partner for customers worldwide. Torrent Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.